The authors used genome-engineered human pluripotent stem cells to express the ETV6-RUNX1 fusion protein and focused on a developmentally restricted CD19− IL7R+ progenitor that was hypothesised to be the B-ALL cell of origin. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.